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Amyloidosis is a group of rare but serious diseases caused by deposits of amyloid substance in tissues and organs throughout the body. It can be classified in primary  or 
Amyloidosis AL, usually with no evidence of preceding or coexisting disease; associated with multiple myeloma; or secondary with evidence of coexisting previous chronic 
inflammatory or infectious conditions. Our aim is to demonstrate the importance of considering amyloidosis as a diagnosis in a patient with multiple organ failure of 
undetermined etiology. 
Clinical Case 
Sixty-six year’s old male with one year history of chronic liver and kidney disease (stage 3) of undetermined etiology was admitted, to our Ward, for declined renal function 
with hyperkalemia and right heart failure signs. 
Physical examination was remarkable for hepatomegaly, ascites and oedema of the lower limbs.  
Full Blood Count 
Erythrocites (4-5 10*12/L) 4.35 
Hemoglobin (12-16 g/dL) 12.3 
Leucocytes (4.0-11 10*9/L) 13.80 
Platelets (150-400 10*9/L) 244 
Coagulation 
PT (8.0-14.0 sec)  14.1 
aPTT (25.0-35.0 sec)  31 
Biochemistry 
Glucose (75-110 mg/dl ) 89 
Urea (10-50 mg/dl) 135 
Creatinine (0.6-1.1 mg/dl) 3.5 
Potassium (3.5-5.1 mEq/L) 5.5 
Sodium (136-147 mEq/L ) 145 
Calcium (4.05-5.2 mEq/L) 5 
Phosphorus (2.7-4.5 mg/dl) 4.4 
Bilirrubin (<1.2 mg/dl) 0.63 
AST (10-31 U/L) 33 
ALT (10-31 U/L ) 23 
Ferritin (26-388 ng/mL) 111 
ß2 microglobulin (1090-2530 ng/mL) 15007 
LDH (135-225 U/L ) 234 
C-reactive Protein (<3 mg/L) 27.2 
Serum proteins (6.4-8.2 g/dl) 5.5 
Albumin (3.4 -5 g/dl) 1.9 
Creatinine Kinase  (39-380 U/L) 69 
PBNP (<125 pg/ml) 1357 
Autoimmune panel and viral serologies negative. 
Bone marrow aspirate: 5% plasmocytes. 
ECG: Sinus rythm, low voltage. 
Abdominal US: hepatomegaly (23 cm), bosselated and 
hyperechogenic eco-structure, diffusely derranged with no focal 
alterations. Moderate ascites. Kidneys with diminished 
parenchyma volume in favour of chronic nephropathy. 
Echocardiogram: left ventricle wall thickned with heterogen tissue 
aspect in favour of  an infiltrative process. 
For systemic AL amyloidosis with heart, liver and kidney involvement, Dexamethasone (100% dose) was started alongside Cyclophosphamide (33% dose) and 
Bortezomib (100% dose). Despite prompt action the patient died within days.  
The clinical case enhances the importance of early investigation and capacity of integrating combined organ involvement and analytical changes to fit 
one consistent diagnosis. 
Liver biopsy – Hepatic deposition of AL amiyloid substance. 
Proteinuria 
Proteins (<0.15 g/24h) 5.4 
